Role of nanotechnology in the prolonged release of drugs by the subcutaneous route

References

• Le J. Drug administration - drugs - MSD Manual Consumer Version. 2016. [cited Apr, 2022]. Available from: https://www.msdmanuals.com/home/drugs/administration-and-kinetics-of-drugs/drug-administration
   Google Scholar
• Zhou Q, Jin J, Zhu L, et al. The optimal choice of medication administration route regarding intravenous, intramuscular, and subcutaneous injection. Patient Prefer Adherence. 2015;9:923.
   PubMed Web of Science ®Google Scholar
• Elsamany SA, Jafal M, Hassanin F. Pharmaco-economic assessment of subcutaneous compared to intravenous trastuzumab in HER2-positive breast cancer patients: a single institution experience. J Clin Oncol. 2020;38:e19409.
   Web of Science ®Google Scholar
• Viola M, Sequeira J, Seiça R, et al. Subcutaneous delivery of monoclonal antibodies: how do we get there? J Control Release. 2018;286:301–314.
   PubMed Web of Science ®Google Scholar
• Patra JK, Das G, Fraceto LF, et al. Nano based drug delivery systems: recent developments and future prospects. J Nanobiotechnology. 2018;16:1–33.
   PubMed Web of Science ®Google Scholar
• Halwani AA. Development of pharmaceutical nanomedicines: from the bench to the market. Pharmaceutics. 2022;14:106.
   PubMed Web of Science ®Google Scholar
• Kalaydina RV, Bajwa K, Qorri B, et al. Recent advances in “smart” delivery systems for extended drug release in cancer therapy. Int J Nanomedicine. 2018;13:4727–4745.
   PubMed Web of Science ®Google Scholar
• Farjadian F, Ghasemi A, Gohari O, et al. Nanopharmaceuticals and nanomedicines currently on the market: challenges and opportunities. Nanomedicine. 2019;14:93–126.
   PubMed Web of Science ®Google Scholar
• FDA approves first COVID-19 vaccine.[cited Jun 21, 2022]. Available from: https://www.fda.gov/news-events/press-announcements/fda-approves-first-covid-19-vaccine
   Google Scholar
• Coronavirus (COVID-19) update: fDA takes key action by approving second COVID-19vaccine. [cited Jun 21, 2022]. Available from: https://www.fda.gov/news-events/press-announcements/coronavirus-covid-19-update-fda-takes-key-action-approving-second-covid-19-vaccine
   Google Scholar
• Richter WF, Bhansali SG, Morris ME. Mechanistic determinants of biotherapeutics absorption following SC administration. Aaps J. 2012;14:559–570.
   PubMed Web of Science ®Google Scholar
• Luo L, Liu M. Adipose tissue in control of metabolism. J Endocrinol. 2016;231:R77–99.
   PubMed Web of Science ®Google Scholar
• Kendall RT, Feghali-Bostwick CA. Fibroblasts in fibrosis: novel roles and mediators. Front Pharmacol. 2014;5:77–99.
   PubMed Web of Science ®Google Scholar
• Frost GI. Recombinant human hyaluronidase (rHuph20): an enabling platform for subcutaneous drug and fluid administration. Expert Opin Drug Deliv. 2007;4:427–440.
   PubMed Web of Science ®Google Scholar
• Varkhede N, Bommana R, Schöneich C, et al. Proteolysis and oxidation of therapeutic proteins after intradermal or subcutaneous administration. J Pharm Sci. 2020;109:191–205.
   PubMed Web of Science ®Google Scholar
• Sequeira JAD, Santos AC, Serra J, et al. Subcutaneous delivery of biotherapeutics: challenges at the injection site. Expert Opin Drug Deliv. 2019;16:143–151.
   PubMed Web of Science ®Google Scholar
• Rasmussen CH, Røge RM, Ma Z, et al. Insulin aspart pharmacokinetics: an assessment of its variability and underlying mechanisms. Eur J Pharm Sci. 2014;62:65–75.
   PubMed Web of Science ®Google Scholar
• Breslin JW, Yang Y, Scallan JP, et al. Lymphatic vessel network structure and physiology. Compr Physiol Wiley. 2018;9:207–299.
   PubMed Web of Science ®Google Scholar
• Moore JE, Bertram CD. Lymphatic system flows. 2017; [cited Mar 21, 2023]. Available from: http://doi.org/10.1146/annurev-fluid-122316
   Google Scholar
• Charman WN, Stella VJ. Lymphatic transport of drugs . New York: CRC Press; 1992.
   Google Scholar
• McCright J, Naiknavare R, Yarmovsky J, et al. Targeting lymphatics for nanoparticle drug delivery. Front Pharmacol. 2022;13:887402.
   PubMed Web of Science ®Google Scholar
• Stack T, Liu Y, Frey M, et al. Enhancing subcutaneous injection and target tissue accumulation of nanoparticles: via co-administration with macropinocytosis inhibitory nanoparticles (MiNP). Nanoscale Horiz. 2021;6:393–400.
   PubMed Web of Science ®Google Scholar
• Liu J, Liu Z, Pang Y, et al. The interaction between nanoparticles and immune system: application in the treatment of inflammatory diseases. J Nanobiotechnology. 2022;20:1–25.
   PubMed Web of Science ®Google Scholar
• Mitchell MJ, Billingsley MM, Haley RM, et al. Engineering precision nanoparticles for drug delivery. Nat Rev Drug Discov. 2021;20:101–124.
   PubMed Web of Science ®Google Scholar
• Li Z, Zhu Y, Zeng H, et al. Mechano-boosting nanomedicine antitumour efficacy by blocking the reticuloendothelial system with stiff nanogels. Nat Commun. 2023;14:1437.
   PubMedGoogle Scholar
• Burke JA, Zhang X, Bobbala S, et al. Subcutaneous nanotherapy repurposes the immunosuppressive mechanism of rapamycin to enhance allogeneic islet graft viability. Nat Nanotechnol. 2022;17:319–330.
   PubMed Web of Science ®Google Scholar
• Maisel K, Hrusch CL, Medellin JEG, et al. Pro-lymphangiogenic VEGFR-3 signaling modulates memory T cell responses in allergic airway inflammation. Mucosal Immunol. 2021;14:144–151.
   PubMed Web of Science ®Google Scholar
• McCright J, Skeen C, Yarmovsky J, et al. Nanoparticles with dense poly(ethylene glycol) coatings with near neutral charge are maximally transported across lymphatics and to the lymph nodes. Acta Biomater. 2022;145:146–158.
   PubMed Web of Science ®Google Scholar
• Nakamura T, Kawai M, Sato Y, et al. The effect of size and charge of lipid nanoparticles prepared by microfluidic mixing on their lymph node transitivity and distribution. Mol Pharm. 2020;17:944–953.
   PubMedGoogle Scholar
• Rao DA, Forrest ML, Alani AWG, et al. Biodegradable PLGA based nanoparticles for sustained regional lymphatic drug delivery. J Pharm Sci. 2010;99:2018–2031.
   PubMed Web of Science ®Google Scholar
• Helle M, Rampazzo E, Monchanin M, et al. Surface chemistry architecture of silica nanoparticles determine the efficiency of in vivo fluorescence lymph node mapping. ACS Nano. 2013;7:8645–8657.
   PubMed Web of Science ®Google Scholar
• Rahimi E, Aramideh S, Han D, et al. Transport and lymphatic uptake of monoclonal antibodies after subcutaneous injection. Microvasc Res. 2022;139:104228.
   PubMed Web of Science ®Google Scholar
• Ke X, Howard GP, Tang H, et al. Physical and chemical profiles of nanoparticles for lymphatic targeting. Adv Drug Deliv Rev. 2019;151–152:72–93.
   PubMed Web of Science ®Google Scholar
• Bittner B, Richter W, Schmidt J. Subcutaneous administration of biotherapeutics: an overview of current challenges and opportunities. BioDrugs. 2018;32:425–440.
   PubMed Web of Science ®Google Scholar
• Reddy ST, Berk DA, Jain RK, et al. A sensitive in vivo model for quantifying interstitial convective transport of injected macromolecules and nanoparticles. J Appl Physiol. 2006;101:1162–1169.
   PubMed Web of Science ®Google Scholar
• Collins DS, Kourtis LC, Thyagarajapuram NR, et al. Optimizing the bioavailability of subcutaneously administered biotherapeutics through mechanochemical drivers. Pharm Res. 2017;34:2000–2011.
   PubMed Web of Science ®Google Scholar
• Vijayakumar A, Sharon E, Teena J, et al. A clinical study on drug-related problems associated with intravenous drug administration. J Basic Clin Pharm. 2014;5:49–53.
   PubMedGoogle Scholar
• Haeri A, Osouli M, Bayat F, et al. Nanomedicine approaches for sirolimus delivery: a review of pharmaceutical properties and preclinical studies. Artif Cells Nanomed Biotechnol. 2018;46:1–14.
   PubMed Web of Science ®Google Scholar
• Davies N, Hovdal D, Edmunds N, et al. Functionalized lipid nanoparticles for subcutaneous administration of mRNA to achieve systemic exposures of a therapeutic protein. Mol Ther Nucleic Acids. 2021;24:369–384.
   PubMedGoogle Scholar
• Wang L, Liu G, Hu Y, et al. Doxorubicin-loaded polypyrrole nanovesicles for suppressing tumor metastasis through combining photothermotherapy and lymphatic system-targeted chemotherapy. Nanoscale. 2022;14:3097–3111.
   PubMed Web of Science ®Google Scholar
• Clair-Jones A S, Prignano F, Goncalves J, et al. Understanding and minimising injection-site pain following subcutaneous administration of biologics: a narrative review. Rheumatol Ther. 2020;7:741–757.
   PubMed Web of Science ®Google Scholar
• Woodley WD, Morel DR, Sutter DE, et al. Clinical evaluation of large volume subcutaneous injection tissue effects, pain, and acceptability in healthy adults. Clin Transl Sci. 2022;15:92–104.
   PubMed Web of Science ®Google Scholar
• Jiskoot W, Hawe A, Menzen T, et al. Ongoing challenges to develop high concentration monoclonal antibody-based formulations for subcutaneous administration: quo vadis? J Pharm Sci. 2022;111:861–867.
   PubMed Web of Science ®Google Scholar
• Heo YA, Syed YY. Subcutaneous trastuzumab: a review in HER2-Positive Breast Cancer. Target Oncol. 2019;14:749–758.
   PubMed Web of Science ®Google Scholar
• Wasserman RL. Clinical practice experience with HyQvia in adults using alternative dosing regimens and pediatric patients: a retrospective study. Adv Ther. 2020;37:1536–1549.
   PubMed Web of Science ®Google Scholar
• Locke KW, Maneval DC, LaBarre MJ. ENHANZE® drug delivery technology: a novel approach to subcutaneous administration using recombinant human hyaluronidase PH20. Drug Deliv. 2019;26:98–106.
   PubMed Web of Science ®Google Scholar
• Chen W, Yung BC, Qian Z, et al. Improving long-term subcutaneous drug delivery by regulating material-bioenvironment interaction. Adv Drug Deliv Rev. 2018;127:20–34.
   PubMed Web of Science ®Google Scholar
• Kastellorizios M, Tipnis N, Burgess DJ. Foreign body reaction to subcutaneous implants. Adv Exp Med Biol Springer New York. 2015;LLC:93–108.
   Google Scholar
• Karabin NB, Allen S, Kwon H-K, et al. Sustained micellar delivery via inducible transitions in nanostructure morphology. Nat Commun. 2018;9:624.
   PubMed Web of Science ®Google Scholar
• Kharbikar BN, Chendke GS, Desai TA. Modulating the foreign body response of implants for diabetes treatment. Adv Drug Deliv Rev. 2021;174:87–113.
   PubMed Web of Science ®Google Scholar
• Jogpal V, Sanduja M, Dutt R, et al. Advancement of nanomedicines in chronic inflammatory disorders. Inflammopharmacology. 2022;30:355–368.
   PubMed Web of Science ®Google Scholar
• Sercombe L, Veerati T, Moheimani F, et al. Advances and challenges of liposome assisted drug delivery. Front Pharmacol. 2015;6:286.
   PubMed Web of Science ®Google Scholar
• Wang P, Perche F, Midoux P, et al. In Vivo bone tissue induction by freeze-dried collagen-nanohydroxyapatite matrix loaded with BMP2/NS1 mRnas lipopolyplexes. J Control Release. 2021;334:188–200.
   PubMed Web of Science ®Google Scholar
• Korupalli C, Pan WY, Yeh CY, et al. Single-injecting, bioinspired nanocomposite hydrogel that can recruit host immune cells in situ to elicit potent and long-lasting humoral immune responses. Biomaterials. 2019;216:119268.
   PubMed Web of Science ®Google Scholar
• Zhang ZQ, Kim YM, Song SC. Injectable and quadruple-functional hydrogel as an alternative to intravenous delivery for enhanced tumor targeting. ACS Appl Mater Interfaces. 2019;11:34634–34644.
   PubMed Web of Science ®Google Scholar
• Suk JS, Xu Q, Kim N, et al. Pegylation as a strategy for improving nanoparticle-based drug and gene delivery. Adv Drug Deliv Rev. 2016;99:28–51.
   PubMed Web of Science ®Google Scholar
• Leung AKK, Tam YYC, Chen S, et al. Microfluidic mixing: a general method for encapsulating macromolecules in lipid nanoparticle systems. J Phys Chem B. 2015;119:8698–8706.
   PubMed Web of Science ®Google Scholar
• Berraondo P, Martini PGV, Avila MA, et al. Messenger RNA therapy for rare genetic metabolic diseases. Gut. 2019;68:1323–1330.
   PubMed Web of Science ®Google Scholar
• Kulkarni JA, Witzigmann D, Leung J, et al. On the role of helper lipids in lipid nanoparticle formulations of siRNA. Nanoscale. 2019;11:21733–21739.
   PubMed Web of Science ®Google Scholar
• Volpatti LR, Matranga MA, Cortinas AB, et al. Glucose-responsive nanoparticles for rapid and extended self-regulated insulin delivery. ACS Nano. 2020;14:488–497.
   PubMed Web of Science ®Google Scholar
• Yang W, Liang H, Ma S, et al. Gold nanoparticle based photothermal therapy: development and application for effective cancer treatment. Sustainable Mater Technol. 2019;22:e00109.
   Web of Science ®Google Scholar
• Tanaka M, Hayashi M, Roach L, et al. Synthesis of near-infrared absorbing triangular Au nanoplates using biomineralisation peptides. Acta Biomater. 2021;131:519–531.
   PubMed Web of Science ®Google Scholar
• Arias L, Pessan J, Vieira A, et al. Iron oxide nanoparticles for biomedical applications: a perspective on synthesis, drugs, antimicrobial activity, and toxicity. Antibiotics. 2018;7:46.
   Google Scholar
• Kim SH, Thambi T, Giang Phan VH, et al. Modularly engineered alginate bioconjugate hydrogel as biocompatible injectable scaffold for in situ biomineralization. Carbohydr Polym. 2020;233:233.
   Web of Science ®Google Scholar
• Bahari Javan N, Montazeri H, Rezaie Shirmard L, et al. Preparation, characterization and in vivo evaluation of a combination delivery system based on hyaluronic acid/jeffamine hydrogel loaded with PHBV/PLGA blend nanoparticles for prolonged delivery of Teriparatide. Eur J Pharm Sci. 2017;101:167–181.
   PubMed Web of Science ®Google Scholar
• Cao S, Liu Y, Shang H, et al. Supramolecular nanoparticles of calcitonin and dipeptide for long-term controlled release. J Control Release. 2017;256:182–192.
   PubMed Web of Science ®Google Scholar
• Bordat A, Boissenot T, Ibrahim N, et al. A Polymer prodrug strategy to switch from intravenous to subcutaneous cancer therapy for irritant/vesicant drugs. J Am Chem Soc. 2022;144:18844–18860.
   PubMedGoogle Scholar
• Thambi T, Giang Phan VH, Kim SH, et al. Smart injectable biogels based on hyaluronic acid bioconjugates finely substituted with poly(β-amino ester urethane) for cancer therapy. Biomater Sci. 2019;7:5424–5437.
   PubMed Web of Science ®Google Scholar
• Vogus DR, Evans MA, Pusuluri A, et al. A hyaluronic acid conjugate engineered to synergistically and sequentially deliver gemcitabine and doxorubicin to treat triple negative breast cancer. J Control Release. 2017;267:191–202.
   PubMed Web of Science ®Google Scholar
• Lee ALZ, Yang C, Gao S, et al. Subcutaneous vaccination using injectable biodegradable hydrogels for long-term immune response. Nanomedicine. 2019;21:102056.
   PubMed Web of Science ®Google Scholar
• Kristó K, Szekeres M, Makai Z, et al. Preparation and investigation of core-shell nanoparticles containing human interferon-α. Int J Pharm. 2020;573:118825.
   PubMedGoogle Scholar
• Rezaie Shirmard L, Ghofrani M, Bahari Javan N, et al. Improving the in-vivo biological activity of fingolimod loaded PHBV nanoparticles by using hydrophobically modified alginate. Drug Dev Ind Pharm. 2020;46:318–328.
   PubMed Web of Science ®Google Scholar
• Jeong DI, Kim S, Kim M-H, et al. Donepezil hydrochloride-reinforced cellulose nanocrystal-aggregated gel structure for long-acting drug delivery. Carbohydr Polym. 2022;296:119887.
   PubMed Web of Science ®Google Scholar
• Chendke GS, Faleo G, Juang C, et al. Supporting survival of transplanted stem‐cell‐derived insulin‐producing cells in an encapsulation device augmented with controlled release of amino acids. Adv Biosyst. 2019;3:1900086.
   PubMed Web of Science ®Google Scholar
• Trinh TA, Duy Le TM, HGV H, et al. A novel injectable Ph-temperature sensitive hydrogel containing chitosan-insulin electrosprayed nanosphere composite for an insulin delivery system in type i diabetes treatment. Biomater Sci. 2020;8:3830–3843.
   PubMed Web of Science ®Google Scholar
• Tong F. Preparation of exenatide-loaded linear poly(ethylene glycol)-brush poly(l-lysine) block copolymer: potential implications on diabetic nephropathy. Int J Nanomedicine. 2017;12:4663–4678.
   PubMed Web of Science ®Google Scholar
• Dong N, Zhu C, Jiang J, et al. Development of composite PLGA microspheres containing exenatide-encapsulated lecithin nanoparticles for sustained drug release. Asian J Pharm Sci. 2020;15:347–355.
   PubMed Web of Science ®Google Scholar
• Seo BB, Park MR, Song SC. Sustained release of exendin 4 using injectable and ionic-nano-complex forming polymer hydrogel system for long-term treatment of type 2 diabetes mellitus. ACS Appl Mater Interfaces. 2019;11:15201–15211.
   PubMed Web of Science ®Google Scholar
• Filipović N, Veselinović L, Ražić S, et al. Poly (ε-caprolactone) microspheres for prolonged release of selenium nanoparticles. Mater Sci Eng C. 2019;96:776–789.
   PubMed Web of Science ®Google Scholar
• Sigfridsson K, Xue A, Goodwin K, et al. Sustained release and improved bioavailability in mice after subcutaneous administration of griseofulvin as nano- and microcrystals. Int J Pharm. 2019;566:565–572.
   PubMedGoogle Scholar
• Tanaudommongkon I, Tanaudommongkon A, Dong X. Development of in situ self-assembly nanoparticles to encapsulate lopinavir and ritonavir for long-acting subcutaneous injection. Pharmaceutics. 2021;13:904.
   PubMed Web of Science ®Google Scholar
• Duong V-A, Nguyen T-T-L, Maeng H-J, et al. Preparation of ondansetron hydrochloride-loaded nanostructured lipid carriers using solvent injection method for enhancement of pharmacokinetic properties. Pharm Res. 2019;36:138.
   PubMed Web of Science ®Google Scholar
• Elbrink K, van Hees S, Chamanza R, et al. Application of solid lipid nanoparticles as a long-term drug delivery platform for intramuscular and subcutaneous administration: in vitro and in vivo evaluation. Eur J Pharm Biopharm. 2021;163:158–170.
   PubMed Web of Science ®Google Scholar
• Prakapenka AV, Quihuis AM, Carson CG, et al. Poly(lactic-co-glycolic acid) nanoparticle encapsulated 17β-estradiol improves spatial memory and increases uterine stimulation in middle-aged ovariectomized rats. Front Behav Neurosci. 2020;14:597690.
   PubMed Web of Science ®Google Scholar
• Park J-S, Lee D, Yang S, et al. Methotrexate-loaded nanoparticles ameliorate experimental model of autoimmune arthritis by regulating the balance of interleukin-17-producing T cells and regulatory T cells. J Transl Med. 2022;20:1–11.
   PubMed Web of Science ®Google Scholar
• Kovalainen M, Mönkäre J, Kaasalainen M, et al. Development of porous silicon nanocarriers for parenteral peptide delivery. Mol Pharm. 2013;10:353–359.
   PubMed Web of Science ®Google Scholar
• Sozen T, Ozisik L, Calik Basaran N. An overview and management of osteoporosis. Eur J Rheumatol. 2017;4:46–56.
   PubMed Web of Science ®Google Scholar
• Chesnut CH, Azria M, Silverman S, et al. Salmon calcitonin: a review of current and future therapeutic indications. Osteoporos Int. 2008;19:479–491.
   PubMed Web of Science ®Google Scholar
• Canalis E. Management of endocrine disease: novel anabolic treatments for osteoporosis. Eur J Endocrinol. 2018;178:33–44.
   PubMed Web of Science ®Google Scholar
• Reid IR, Billington EO. Drug therapy for osteoporosis in older adults. Lancet. 2022;399:1080–1092.
   PubMed Web of Science ®Google Scholar
• Sun B, Luo C, Yu H, et al. Disulfide bond-driven oxidation- and reduction-responsive prodrug nanoassemblies for cancer therapy. Nano Lett. 2018;18:3643–3650.
   PubMed Web of Science ®Google Scholar
• Li N, Guo W, Li Y, et al. Construction and anti-tumor activities of disulfide-linked docetaxel-dihydroartemisinin nanoconjugates. Colloids Surf B Biointerfaces. 2020;191:111018.
   PubMed Web of Science ®Google Scholar
• Wang Z, Ling L, Du Y, et al. Reduction responsive liposomes based on paclitaxel-ss-lysophospholipid with high drug loading for intracellular delivery. Int J Pharm. 2019;564:244–255.
   PubMedGoogle Scholar
• Lu J, Huang Y, Zhao W, et al. PEG-derivatized embelin as a nanomicellar carrier for delivery of paclitaxel to breast and prostate cancers. Biomaterials. 2013;34:1591–1600.
   PubMed Web of Science ®Google Scholar
• Barbee MS, Owonikoko TK, Harvey RD. Taxanes: vesicants, irritants, or just irritating? Ther Adv Med Oncol. 2014;6:16–20.
   PubMed Web of Science ®Google Scholar
• Zhao N, Woodle CM, Mixson AJ. Advances in delivery systems for doxorubicin. J Nanomed Nanotechnol. 2018;09:1000519.
   Google Scholar
• Kanwal U, Irfan Bukhari N, Ovais M, et al. Advances in nano-delivery systems for doxorubicin: an updated insight. J Drug Target. 2018;26:296–310.
   PubMed Web of Science ®Google Scholar
• Wang Y, Yang ST, Wang Y, et al. Adsorption and desorption of doxorubicin on oxidized carbon nanotubes. Colloids Surf B Biointerfaces. 2012;97:62–69.
   PubMed Web of Science ®Google Scholar
• Zha Z, Yue X, Ren Q, et al. Uniform polypyrrole nanoparticles with high photothermal conversion efficiency for photothermal ablation of cancer cells. Adv Mater. 2013;25:777–782.
   PubMed Web of Science ®Google Scholar
• Wang T, Yang L, Xie Y, et al. An injectable hydrogel/staple fiber composite for sustained release of CA4P and doxorubicin for combined chemotherapy of xenografted breast tumor in mice. Nan Fang Yi Ke Da Xue Xue Bao. 2022;42:625–632.
   PubMedGoogle Scholar
• Rosenblum D, Joshi N, Tao W, et al. Progress and challenges towards targeted delivery of cancer therapeutics. Nat Commun. 2018;9:1410.
   PubMed Web of Science ®Google Scholar
• Vincent MP, Bobbala S, Karabin NB, et al. Surface chemistry-mediated modulation of adsorbed albumin folding state specifies nanocarrier clearance by distinct macrophage subsets. Nat Commun. 2021;12:648.
   PubMed Web of Science ®Google Scholar
• Vincent MP, Navidzadeh JO, Bobbala S, et al. Leveraging self-assembled nanobiomaterials for improved cancer immunotherapy. Cancer Cell. 2022;40:255–276.
   PubMed Web of Science ®Google Scholar
• Cohen JA, Tenenbaum N, Bhatt A, et al. Extended treatment with fingolimod for relapsing multiple sclerosis: the 14-year LONGTERMS study results. Ther Adv Neurol Disord. 2019;12:175628641987832.
   Web of Science ®Google Scholar
• Singer BA. Initiating oral fingolimod treatment in patients with multiple sclerosis. Ther Adv Neurol Disord. 2013;6:269–275.
   PubMed Web of Science ®Google Scholar
• Vargas WS, Perumal JS. Fingolimod and cardiac risk: latest findings and clinical implications. Ther Adv Drug Saf. 2013;4:119–124.
   PubMedGoogle Scholar
• Genuth SM, Palmer JP, Nathan DM. Classification and diagnosis of diabetes. Diabetes in America. Bethesda (MD): National Institute of Diabetes and Digestive and Kidney Diseases (US); 2018. p. 1–39.
   Google Scholar
• Hansen KB, Vilsbøll T, Knop FK. Incretin mimetics: a novel therapeutic option for patients with type 2 diabetes - a review. Diabetes Metab Syndr Obes. 2010;3:155–163.
   PubMedGoogle Scholar
• Seo BB, Park MR, Chun CJ, et al. The biological efficiency and bioavailability of human growth hormone delivered using injectable, ionic, thermosensitive poly(organophosphazene)-polyethylenimine conjugate hydrogels. Biomaterials. 2011;32:8271–8280.
   PubMed Web of Science ®Google Scholar
• Plotkin SA. Correlates of protection induced by vaccination. Clin Vaccin Immunol. 2010;17:1055–1065.
   PubMed Web of Science ®Google Scholar
• Sallusto F, Lanzavecchia A, Araki K, et al. From Vaccines to Memory and Back. Immunity. 2010;33:451–463.
   PubMed Web of Science ®Google Scholar
• Roth GA, Gale EC, Alcantara-Hernandez M, et al. Injectable hydrogels for sustained codelivery of subunit vaccines enhance humoral immunity. ACS Cent Sci. 2020;6:1800–1812.
   PubMed Web of Science ®Google Scholar
• Bailon L, Mothe B, Berman L, et al. Novel Approaches Towards a Functional Cure of HIV/AIDS. Drugs. 2020;80:859–868.
   PubMed Web of Science ®Google Scholar
• Adefolalu A, Nkosi Z. The complex nature of adherence in the management of HIV/AIDS as a chronic medical condition. Diseases. 2013;1:18–35.
   Google Scholar
• Zingg R, Fischer M. The consolidation of nanomedicine. Wiley Interdiscip Rev Nanomed Nanobiotechnol. 2019;11:1–6.
   Web of Science ®Google Scholar
• Foulkes R, Man E, Thind J, et al. The regulation of nanomaterials and nanomedicines for clinical application: current and future perspectives. Biomater Sci. 2020;8:4653–4664.
   PubMed Web of Science ®Google Scholar
• Committee for Medicinal Products for Human Use (CHMP) EMA. Reflection paper on non-clinical studies for generic nanoparticle iron medicinal product applications, EMA/CHMP/SWP/100094/2011. [cited May 24, 2022]. Available from: https://www.ema.europa.eu/en/documents/scientific-guideline/reflection-paper-non-clinical-studies-generic-nanoparticle-iron-medicinal-product-applications_en.pdf
   Google Scholar
• Soares S, Sousa J, Pais A, et al. Nanomedicine: principles, properties, and regulatory issues. Front Chem. 2018;6:1–15.
   PubMed Web of Science ®Google Scholar
• Allen RP, Bolandparvaz A, Ma JA, et al. Latent, immunosuppressive nature of poly(lactic- co -glycolic acid) microparticles. ACS Biomater Sci Eng. 2018;4:900–918.
   PubMed Web of Science ®Google Scholar
• Epstein RS. Payer perspectives on intravenous versus subcutaneous administration of drugs. Clinicoecon Outcomes Res. 2021;13:801–807.
   PubMed Web of Science ®Google Scholar
• Danaei M, Dehghankhold M, Ataei S, et al. Impact of particle size and polydispersity index on the clinical applications of lipidic nanocarrier systems. Pharmaceutics. 2018;10:57.
   PubMed Web of Science ®Google Scholar
• Blanco E, Shen H, Ferrari M. Principles of nanoparticle design for overcoming biological barriers to drug delivery. Nat Biotechnol. 2015;33:941–951.
   PubMed Web of Science ®Google Scholar
• Bastogne T. Quality-by-design of nanopharmaceuticals – a state of the art. Nanomedicine. 2017;13:2151–2157.
   PubMed Web of Science ®Google Scholar
• Rawal M, Singh A, Amiji MM. Quality-by-design concepts to improve nanotechnology-based drug development. Pharm Res. 2019;36:1–20.
   Web of Science ®Google Scholar
• Pallagi E, Ismail R, Paál TL, et al. Initial risk assessment as part of the quality by design in peptide drug containing formulation development. Eur J Pharm Sci. 2018;122:160–169.
   PubMed Web of Science ®Google Scholar
• Thanki K, Zeng X, Justesen S, et al. Engineering of small interfering RNA-loaded lipidoid-poly(DL-lactic-co-glycolic acid) hybrid nanoparticles for highly efficient and safe gene silencing: a quality by design-based approach. Eur J Pharm Biopharm. 2017;120:22–33.
   PubMed Web of Science ®Google Scholar
• Gupta A, Costa AP, Xu X, et al. Formulation and characterization of curcumin loaded polymeric micelles produced via continuous processing. Int J Pharm. 2020;583:119340.
   PubMedGoogle Scholar
• Alexis F, Pridgen E, Molnar LK, et al. Factors affecting the clearance and biodistribution of polymeric nanoparticles. Mol Pharm. 2008;5:505–515.
   PubMed Web of Science ®Google Scholar
• Zagalo DM, Silva BMA, Silva C, et al. A quality by design (QbD) approach in pharmaceutical development of lipid-based nanosystems: a systematic review. J Drug Deliv Sci Technol. 2022;70:103207.
   Web of Science ®Google Scholar
• Omar Zaki SS, Ibrahim MN, Katas H. Particle size affects concentration-dependent cytotoxicity of chitosan nanoparticles towards mouse hematopoietic stem cells. J Nanotechnol. 2015;2015:1–5.
   Google Scholar
• Egorov E, Pieters C, Korach-Rechtman H, et al. Robotics, microfluidics, nanotechnology and AI in the synthesis and evaluation of liposomes and polymeric drug delivery systems. Drug Deliv Transl Res. 2021;11:345–352.
   PubMed Web of Science ®Google Scholar
• Villa Nova M, Lin TP, Shanehsazzadeh S, et al. Nanomedicine ex machina: between model-informed development and artificial intelligence. Front Digit Health. 2022;4:1–12.
   Google Scholar
• Sarker IH. Machine learning: algorithms, real-world applications and research directions. SN Comput Sci. 2021;2:1–21.
   Google Scholar
• Shabanzadeh P, Senu N, Shameli K, et al. Artificial intelligence in numerical modeling of silver nanoparticles prepared in montmorillonite interlayer space. J Chem. 2013;2013:1–8.
   Web of Science ®Google Scholar
• Li Y, Abbaspour MR, Grootendorst PV, et al. Optimization of controlled release nanoparticle formulation of verapamil hydrochloride using artificial neural networks with genetic algorithm and response surface methodology. Eur J Pharm Biopharm. 2015;94:170–179.
   PubMed Web of Science ®Google Scholar
• Zaki MR, Varshosaz J, Fathi M. Preparation of agar nanospheres: comparison of response surface and artificial neural network modeling by a genetic algorithm approach. Carbohydr Polym. 2015;122:314–320.
   PubMed Web of Science ®Google Scholar
• Hashad RA, Ishak RAH, Fahmy S, et al. Chitosan-tripolyphosphate nanoparticles: optimization of formulation parameters for improving process yield at a novel pH using artificial neural networks. Int j biol macromol. 2016;86:50–58.
   PubMed Web of Science ®Google Scholar
• Baharifar H, Amani A. Size, loading efficiency, and cytotoxicity of albumin-loaded chitosan nanoparticles: an artificial neural networks study. J Pharm Sci. 2017;106:411–417.
   PubMed Web of Science ®Google Scholar
• Youshia J, Ali ME, Lamprecht A. Artificial neural network based particle size prediction of polymeric nanoparticles. Eur J Pharm Biopharm. 2017;119:333–342.
   PubMed Web of Science ®Google Scholar
• Kanwal U, Bukhari NI, Rana NF, et al. Doxorubicin-loaded quaternary ammonium palmitoyl glycol chitosan polymeric nanoformulation: uptake by cells and organs. Int J Nanomedicine. 2019;14:1–15.
   PubMed Web of Science ®Google Scholar
• Öztürk AA, Gündüz AB, Ozisik O. Supervised machine learning algorithms for evaluation of solid lipid nanoparticles and particle size. Comb Chem High Throughput Screen. 2018;21:693–699.
   PubMed Web of Science ®Google Scholar
• He Y, Ye Z, Liu X, et al. Can machine learning predict drug nanocrystals? J Control Release. 2020;322:274–285.
   PubMed Web of Science ®Google Scholar
• Lazarovits J, Sindhwani S, Tavares AJ, et al. Supervised learning and mass spectrometry predicts the in vivo fate of nanomaterials. ACS Nano. 2019;13:8023–8034.
   PubMed Web of Science ®Google Scholar
• Li F, Han J, Cao T, et al. Design of self-assembly dipeptide hydrogels and machine learning via their chemical features. PNAS. 2019;116:11259–11264.
   PubMed Web of Science ®Google Scholar